Trending Topic

9 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Birjis Fatma, Syed Shoeb Ahmad, Abid Nadeem Nomani

Breast carcinoma is the most common cancer in females. An estimated 2.3 million new cases of breast carcinoma are diagnosed annually worldwide.1 These patients have potential risks of ocular complications not only from the secondaries in the eye but also due to the side effects of medications such as corticosteroids and cytotoxic drugs used to treat […]

Basil K Williams, Hawaiian Eye 2022: Retinoblastoma and Uveal Melanoma

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Feb 8th 2022

The field of ocular oncology is rapidly changing, according to a presentation at Hawaiian Eye 2022. It was a pleasure to speak with Dr Basil K Williams (University of Cincinnati, Cincinnati, OH, USA) on the topic of retinoblastoma and its challenges, and treatment options for uveal melanoma.

The abstract entitled What’s New in the World of Ocular Oncology? was presented at Hawaiian Eye 2022, 15–21 January 2022.  

Questions

  1. Could you tell us a little about retinoblastoma and its challenges? (00:16)
  2. What are the most important evolving treatment options for uveal melanoma? (01:40)
  3. What new treatments and technology do you expect to emerge in the coming year? (03:25)

Speaker Disclosure: Basil K Williams is a consultant for Allergan, Castle Biosciences and Genentech.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed in coverage of Hawaiian Eye 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup